Literature DB >> 20471183

Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries.

Dorothy M Gujral1, Georges Sumo, John R Owen, Anita Ashton, Judith M Bliss, Joanne Haviland, John R Yarnold.   

Abstract

PURPOSE: The justification for partial breast radiotherapy after breast conservation surgery assumes that ipsilateral breast tumor relapses (IBTR) outside the index quadrant are mostly new primary (NP) tumors that develop despite radiotherapy. We tested the hypothesis that whole-breast radiotherapy (WBRT) is ineffective in preventing NP by comparing development rates in irradiated and contralateral breasts after tumor excision and WBRT. METHODS AND MATERIALS: We retrospectively reviewed 1,410 women with breast cancer who were entered into a prospective randomized trial of radiotherapy fractionation and monitored annually for ipsilateral breast tumor relapses (IBTR) and contralateral breast cancer (CLBC). Cases of IBTR were classified into local recurrence (LR) or NP tumors based on location and histology and were subdivided as definite or likely depending on clinical data. Rates of ipsilateral NP and CLBC were compared over a 15-year period of follow-up.
RESULTS: At a median follow-up of 10.1 years, there were 150 documented cases of IBTR: 118 (79%) cases were definite or likely LR; 27 (18%) cases were definite or likely NP; and 5 (3%) cases could not be classified. There were 71 cases of CLBC. The crude proportion of definite-plus-likely NP was 1.9% (27/1,410) patients compared with 5% (71/1,410) CLBC patients. Cumulative incidence rates at 5, 10, and 15 years were 0.8%, 2.0%, and 3.5%, respectively, for definite-plus-likely NP and 2.4%, 5.8%, and 7.9%, respectively for CLBC, suggesting a difference in the rates of NP and CLBC.
CONCLUSIONS: This analysis suggests that WBRT reduces the rate of ipsilateral NP tumors. The late presentation of NP has implications for the reporting of trials that are testing partial breast radiotherapy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20471183     DOI: 10.1016/j.ijrobp.2009.10.074

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  Intraoperative radiotherapy of the breast - really a valide option or "only" comfortable.

Authors:  Marc D Piroth
Journal:  Gland Surg       Date:  2013-05

2.  Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer : beware of one-stop shops?

Authors:  Marie-Luise Sautter-Bihl; Felix Sedlmayer; Wilfried Budach; Jürgen Dunst; Rita Engenhart-Cabillic; Rainer Fietkau; Petra Feyer; Wulf Haase; Wolfgang Harms; Claus Rödel; Rainer Souchon; Frederik Wenz; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2010-12       Impact factor: 3.621

Review 3.  Intraoperative Period and Breast Cancer: Review.

Authors:  Arzu Akan; Şerife Şimsek
Journal:  J Breast Health       Date:  2014-10-01

4.  Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy.

Authors:  Jona A Hattangadi-Gluth; Jennifer Y Wo; Paul L Nguyen; Rita F Abi Raad; Meera Sreedhara; Andrzej Niemierko; Phoebe E Freer; Dianne Georgian-Smith; Jennifer R Bellon; Julia S Wong; Barbara L Smith; Jay R Harris; Alphonse G Taghian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-19       Impact factor: 7.038

5.  Phase 2 study of pre-excision single-dose intraoperative radiation therapy for early-stage breast cancers: six-year update with application of the ASTRO accelerated partial breast irradiation consensus statement criteria.

Authors:  Noam A Vanderwalde; Ellen L Jones; Randall J Kimple; Dominic T Moore; Nancy Klauber-Demore; Carolyn I Sartor; David W Ollila
Journal:  Cancer       Date:  2013-01-29       Impact factor: 6.860

Review 6.  Current Treatment of Isolated Locoregional Breast Cancer Recurrences.

Authors:  Wolfgang Harms; Andreas Geretschläger; Corinne Cescato; Martin Buess; Dieter Köberle; Branca Asadpour
Journal:  Breast Care (Basel)       Date:  2015-08-21       Impact factor: 2.860

7.  Options for early breast cancer follow-up in primary and secondary care - a systematic review.

Authors:  Frances Taggart; Peter Donnelly; Janet Dunn
Journal:  BMC Cancer       Date:  2012-06-13       Impact factor: 4.430

8.  Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial.

Authors:  Claire Lemanski; David Azria; Sophie Gourgou-Bourgade; Norbert Ailleres; Aurelie Pastant; Philippe Rouanet; Pascal Fenoglietto; Jean-Bernard Dubois; Marian Gutowski
Journal:  Radiat Oncol       Date:  2013-08-01       Impact factor: 3.481

9.  DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer.

Authors:  F Sedlmayer; M-L Sautter-Bihl; W Budach; J Dunst; G Fastner; P Feyer; R Fietkau; W Haase; W Harms; R Souchon; F Wenz; R Sauer
Journal:  Strahlenther Onkol       Date:  2013-10       Impact factor: 3.621

10.  Potential reduction of contralateral second breast-cancer risks by prophylactic mammary irradiation: validation in a breast-cancer-prone mouse model.

Authors:  Igor Shuryak; Lubomir B Smilenov; Norman J Kleiman; David J Brenner
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.